Skip to content

Private appointments in Dubai

Call privately · 058 599 2494
PRIVATE CARETREATMENT & FOLLOW-UP

PRIVATE CARE GUIDE

After treatment: protect the recovery, not just the dose

Complete treatment exactly as directed, follow the infection-specific sexual precautions, make sure relevant partners receive care, and keep the follow-up plan. Persistent or worsening symptoms need reassessment; they should not be covered with another unsupervised antibiotic.

6 min readUpdated 2026-08-12
Private consultation
Following written aftercare at home
AI-generated illustrative image; not a real patient or facility.

What should I do in the first days?

Use the medicine exactly as instructed and check what to do if a dose is missed or vomited. Avoid sharing medicine. Follow written guidance on sex, alcohol, interactions, symptom relief and when to contact the clinic.

Replaceable early-aftercare content image
  • Finish the prescribed course unless a clinician tells you to stop
  • Do not give your medicine to a partner
  • Keep the packaging and written instructions
  • Report a serious reaction promptly
  • Follow the condition-specific sexual precautions

Do I need another test?

Follow-up differs by infection, pregnancy, sample site and symptoms. For chlamydia, CDC guidance commonly advises retesting around three months because reinfection is frequent; a routine test of cure is not the same thing and is used in selected situations.

Replaceable retesting content image

When should symptoms be reviewed?

Seek review if symptoms persist, worsen, return after improving or if a new exposure occurs. Severe pelvic or testicular pain, fever, eye symptoms, neurological symptoms, pregnancy concerns or a spreading rash can require urgent assessment.

Medical sources

CONTINUE THE GUIDE

Back to home

Private consultation

Discuss the result and next step privately.

Complete treatment exactly as directed, follow the infection-specific sexual precautions, make sure relevant partners receive care, and keep the follow-up plan. Persistent or worsening symptoms need reassessment; they should not be covered with another unsupervised antibiotic.